October 2026
This year Sebastian has taken the case for Lowe syndrome, and for rare diseases in general, to rooms where science, policy and capital meet.
Cell & Gene Meeting on the Med. A fireside chat with Jason C. Foster of Ori Biotech on what it takes to develop a therapy for an ultra-rare disease, and a panel on alternative access routes for bespoke gene therapies.
bio:cap, Berlin. Pitching our gene therapy programme at the first edition of the event.
Folkemødet, Bornholm. Pharmadanmark’s panel on rare diseases, with Stine Bosse (European Parliament), Morten Frank Pedersen (Takeda), Stine Hasling Mogensen (Pharmadanmark) and Liselotte Wesley Andersen (Sjældne Diagnoser).
TechBBQ, Copenhagen. Two days at the Walther Therapeutics booth, with Alexander and Francesco on the floor.
Frontiers Health, Berlin. On the speaker line-up, on what it takes to build a gene therapy for a rare disease.
The question was the same everywhere: when a treatment does not exist, how do we make sure patients are not left behind?
All stories